nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Combined strategies for effective cancer immunotherapy with a novel anti-CD47 monoclonal antibody
|
Ni, Haiqing |
|
|
71 |
2 |
p. 353-363 |
artikel |
2 |
Correction to: OSCC cell‑secreted exosomal CMTM6 induced M2‑like macrophages polarization via ERK1/2 signaling pathway
|
Pang, Xin |
|
|
71 |
2 |
p. 505-506 |
artikel |
3 |
Cross-presentation of a TAP-independent signal peptide induces CD8 T immunity to escaped cancers but necessitates anchor replacement
|
Marijt, Koen A. |
|
|
71 |
2 |
p. 289-300 |
artikel |
4 |
Deciphering the immunosuppressive tumor microenvironment in ALK- and EGFR-positive lung adenocarcinoma
|
Budczies, Jan |
|
|
71 |
2 |
p. 251-265 |
artikel |
5 |
Does immune checkpoint inhibitor increase the risks of poor outcomes in COVID-19-infected cancer patients? A systematic review and meta-analysis
|
Lazarus, Gilbert |
|
|
71 |
2 |
p. 373-386 |
artikel |
6 |
Eosinophilic pleural effusion due to lung cancer has a better prognosis than non-eosinophilic malignant pleural effusion
|
Takeuchi, Eiji |
|
|
71 |
2 |
p. 365-372 |
artikel |
7 |
Epigenetic therapy in combination with a multi-epitope cancer vaccine targeting shared tumor antigens for high-risk myelodysplastic syndrome - a phase I clinical trial
|
Holmberg-Thydén, Staffan |
|
|
71 |
2 |
p. 433-444 |
artikel |
8 |
Evaluation of efficacy and toxicity of nivolumab combined with or without docetaxel in patients with advanced NSCLC
|
Wang, Yang |
|
|
71 |
2 |
p. 267-276 |
artikel |
9 |
First-in-human phase 1 study of budigalimab, an anti-PD-1 inhibitor, in patients with non-small cell lung cancer and head and neck squamous cell carcinoma
|
Italiano, Antoine |
|
|
71 |
2 |
p. 417-431 |
artikel |
10 |
Gastric cancer-derived exosomal miR-135b-5p impairs the function of Vγ9Vδ2 T cells by targeting specificity protein 1
|
Li, Juntao |
|
|
71 |
2 |
p. 311-325 |
artikel |
11 |
Identification of KRAS G12V associated clonal neoantigens and immune microenvironment in long-term survival of pancreatic adenocarcinoma
|
Wang, Chao |
|
|
71 |
2 |
p. 491-504 |
artikel |
12 |
Increased TIGIT expressing NK cells with dysfunctional phenotype in AML patients correlated with poor prognosis
|
Liu, Guanfang |
|
|
71 |
2 |
p. 277-287 |
artikel |
13 |
Latency-associated peptide identifies therapeutically resistant muscle-invasive bladder cancer with poor prognosis
|
Ye, Ruiting |
|
|
71 |
2 |
p. 301-310 |
artikel |
14 |
Modulation of CD47-SIRPα innate immune checkpoint axis with Fc-function detuned anti-CD47 therapeutic antibody
|
Narla, Rama Krishna |
|
|
71 |
2 |
p. 473-489 |
artikel |
15 |
Pre-pembrolizumab neutrophil-to-lymphocyte ratio (NLR) predicts the efficacy of second-line pembrolizumab treatment in urothelial cancer regardless of the pre-chemo NLR
|
Kobayashi, Takashi |
|
|
71 |
2 |
p. 461-471 |
artikel |
16 |
Prognostic significance of cachexia in advanced non-small cell lung cancer patients treated with pembrolizumab
|
Jo, Hitomi |
|
|
71 |
2 |
p. 387-398 |
artikel |
17 |
Real-world safety and efficacy data of immunotherapy in patients with cancer and autoimmune disease: the experience of the Hellenic Cooperative Oncology Group
|
Fountzilas, Elena |
|
|
71 |
2 |
p. 327-337 |
artikel |
18 |
SFTPA1 is a potential prognostic biomarker correlated with immune cell infiltration and response to immunotherapy in lung adenocarcinoma
|
Yuan, Lu |
|
|
71 |
2 |
p. 399-415 |
artikel |
19 |
Small cell lung cancer stem cells display mesenchymal properties and exploit immune checkpoint pathways in activated cytotoxic T lymphocytes
|
Kursunel, M. Alper |
|
|
71 |
2 |
p. 445-459 |
artikel |
20 |
T-cell responses and combined immunotherapy against human carbonic anhydrase 9-expressing mouse renal cell carcinoma
|
Harada, Mamoru |
|
|
71 |
2 |
p. 339-352 |
artikel |
21 |
T cells, particularly activated CD4+ cells, maintain anti-CD20-mediated NK cell viability and antibody dependent cellular cytotoxicity
|
Wang, Zhaoming |
|
|
71 |
2 |
p. 237-249 |
artikel |